2016 Q2 Form 10-Q Financial Statement
#000114420416100132 Filed on May 10, 2016
Income Statement
Concept | 2016 Q2 | 2016 Q1 | 2015 Q1 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $2.940M | $3.160M | $3.370M |
YoY Change | 18.07% | -6.23% | 195.61% |
% of Gross Profit | |||
Research & Development | $7.519M | $8.120M | $3.834M |
YoY Change | 61.08% | 111.77% | 28.95% |
% of Gross Profit | |||
Depreciation & Amortization | $18.00K | $18.56K | $13.90K |
YoY Change | 12.5% | 33.47% | 998.26% |
% of Gross Profit | |||
Operating Expenses | $7.519M | $11.28M | $3.834M |
YoY Change | 61.08% | 194.18% | 28.95% |
Operating Profit | -$10.45M | -$7.203M | |
YoY Change | 46.13% | 75.25% | |
Interest Expense | $300.0K | $290.0K | $60.00K |
YoY Change | 42.86% | 383.33% | 50.0% |
% of Operating Profit | |||
Other Income/Expense, Net | $301.9K | $58.27K | |
YoY Change | 42.94% | 44.82% | |
Pretax Income | -$10.15M | -$10.99M | -$7.140M |
YoY Change | 46.29% | 53.92% | 75.43% |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | |||
Net Earnings | -$10.15M | -$10.99M | -$7.145M |
YoY Change | 46.23% | 53.79% | 75.56% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$589.1K | -$637.8K | -$638.6K |
COMMON SHARES | |||
Basic Shares Outstanding | 17.23M shares | 17.23M shares | 10.70M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2016 Q2 | 2016 Q1 | 2015 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $63.50M | $58.30M | $96.10M |
YoY Change | -10.18% | -39.33% | 307.2% |
Cash & Equivalents | $20.34M | $20.40M | $96.05M |
Short-Term Investments | $43.20M | $37.90M | |
Other Short-Term Assets | $600.0K | $800.0K | $283.8K |
YoY Change | -0.85% | 181.85% | 9.51% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $64.10M | $59.10M | $96.34M |
YoY Change | -10.14% | -38.65% | 303.16% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $100.0K | $100.0K | $173.2K |
YoY Change | -42.54% | -42.28% | 1956.36% |
Goodwill | $12.74M | ||
YoY Change | |||
Intangibles | $29.00M | ||
YoY Change | |||
Long-Term Investments | $11.40M | $23.60M | $100.0K |
YoY Change | -63.92% | 23500.0% | |
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $53.10M | $65.40M | $41.96M |
YoY Change | -27.63% | 55.85% | 497966.26% |
TOTAL ASSETS | |||
Total Short-Term Assets | $64.10M | $59.10M | $96.34M |
Total Long-Term Assets | $53.10M | $65.40M | $41.96M |
Total Assets | $117.2M | $124.5M | $138.3M |
YoY Change | -19.01% | -9.98% | 478.56% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.400M | $2.300M | $1.300M |
YoY Change | 84.62% | 76.92% | -9.42% |
Accrued Expenses | $2.600M | $1.200M | $877.5K |
YoY Change | 177.88% | 36.75% | 3120.45% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $5.000M | $3.600M | $2.128M |
YoY Change | 123.22% | 69.14% | 41.89% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $11.60M | $0.00 | $0.00 |
YoY Change | 0.0% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $5.000M | $3.600M | $2.128M |
Total Long-Term Liabilities | $11.60M | $0.00 | $0.00 |
Total Liabilities | $16.60M | $15.20M | $13.70M |
YoY Change | 19.94% | 10.95% | 836.78% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$142.7M | ||
YoY Change | |||
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $100.6M | $109.3M | $124.6M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $117.2M | $124.5M | $138.3M |
YoY Change | -19.0% | -10.01% | 478.75% |
Cashflow Statement
Concept | 2016 Q2 | 2016 Q1 | 2015 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$10.15M | -$10.99M | -$7.145M |
YoY Change | 46.23% | 53.79% | 75.56% |
Depreciation, Depletion And Amortization | $18.00K | $18.56K | $13.90K |
YoY Change | 12.5% | 33.47% | 998.26% |
Cash From Operating Activities | -$6.770M | -$9.210M | -$3.673M |
YoY Change | 54.21% | 150.72% | -29.16% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $2.163K | $30.71K |
YoY Change | -100.0% | -92.96% | 1086.21% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $6.710M | $2.500M | |
YoY Change | -113.76% | ||
Cash From Investing Activities | $6.710M | $2.500M | -$30.71K |
YoY Change | -113.75% | -8240.41% | 1086.21% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 0.000 | $70.67M |
YoY Change | -100.0% | -100.0% | 3908.1% |
NET CHANGE | |||
Cash From Operating Activities | -6.770M | -9.210M | -$3.673M |
Cash From Investing Activities | 6.710M | 2.500M | -$30.71K |
Cash From Financing Activities | 0.000 | 0.000 | $70.67M |
Net Change In Cash | -60.00K | -6.710M | $66.96M |
YoY Change | -99.86% | -110.02% | -2055.38% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$6.770M | -$9.210M | -$3.673M |
Capital Expenditures | $0.00 | $2.163K | $30.71K |
Free Cash Flow | -$6.770M | -$9.212M | -$3.704M |
YoY Change | 54.92% | 148.7% | -28.6% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
29091113 | USD |
CY2016Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
72090 | USD |
CY2015Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
66962969 | USD |
CY2015Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
0 | USD |
CY2015Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
30711 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
0 | USD |
CY2016Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-10916468 | USD |
CY2015Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7144953 | USD |
CY2016Q1 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-201827 | USD |
CY2015Q1 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
0 | USD |
CY2016Q1 | us-gaap |
Depreciation
Depreciation
|
18558 | USD |
CY2015Q1 | us-gaap |
Depreciation
Depreciation
|
13904 | USD |
CY2016Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1459855 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-9210393 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-3673353 | USD |
CY2016Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2163 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
2497912 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-30711 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
70667033 | USD |
CY2016Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-6712481 | USD |
CY2016Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
10451332 | USD |
CY2015Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
0 | USD |
CY2016Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3868597 | shares |
CY2015Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3231246 | shares |
CY2015Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
96054082 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
962450 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
283242 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-796010 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
731120 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
61394 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
158552 | USD |
CY2016Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
7951257 | USD |
CY2015Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
0 | USD |
CY2016Q1 | us-gaap |
Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
|
72090 | USD |
CY2015Q1 | us-gaap |
Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
|
0 | USD |
CY2016Q1 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
0 | USD |
CY2015Q1 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
70499993 | USD |
CY2016Q1 | asmb |
Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
|
0 | USD |
CY2015Q1 | asmb |
Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
|
167040 | USD |
CY2016Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1459855 | USD |
CY2016Q1 | us-gaap |
Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
|
72090 | USD |
CY2016Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
300000 | USD |
CY2015Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
100000 | USD |
CY2016Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1459855 | USD |
CY2015Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2585780 | USD |
CY2016Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1006294 | USD |
CY2015Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1628975 | USD |
CY2016Q1 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
0 | USD |
CY2015Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
106777 | USD |
CY2016Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
236900 | USD |
CY2015Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
182752 | USD |
CY2016Q1 | asmb |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
0 | USD |
CY2015Q4 | asmb |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
120700 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
262956 | USD |
CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
114347 | USD |
CY2016Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2016Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2016Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2016-03-31 | |
CY2016Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2016 | |
CY2016Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2016Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
ASSEMBLY BIOSCIENCES, INC. | |
CY2016Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001426800 | |
CY2016Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2016Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2016Q1 | dei |
Trading Symbol
TradingSymbol
|
ASMB | |
CY2016Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
17225662 | shares |
CY2016Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2016Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2016Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2016Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
17225662 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2016Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2016Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2016Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
17225662 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
17225662 | shares |
CY2016Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
17225662 | shares |
CY2016Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
7121 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-16106 | USD |
CY2016Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Use of Estimates</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Significant estimates inherent in the preparation of the accompanying financial statements include recoverability and useful lives (indefinite) of intangible assets, assessment of impairment of goodwill, and the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2016Q1 | asmb |
Offering Cost Related To Issuance Of Common Stock
OfferingCostRelatedToIssuanceOfCommonStock
|
0 | USD |
CY2015Q1 | asmb |
Offering Cost Related To Issuance Of Common Stock
OfferingCostRelatedToIssuanceOfCommonStock
|
-60000 | USD |
CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
9.42 | |
CY2016Q1 | asmb |
Future Stock Based Compensation Expense Remainder Of Fiscal Year
FutureStockBasedCompensationExpenseRemainderOfFiscalYear
|
3021844 | USD |
CY2016Q1 | asmb |
Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
|
1551027 | USD |
CY2016Q1 | asmb |
Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
|
663555 | USD |
CY2016Q1 | asmb |
Future Stock Based Compensation Expense Year Four
FutureStockBasedCompensationExpenseYearFour
|
191675 | USD |
CY2016Q1 | asmb |
Futurestockbasedcompensationexpenseyearfive
Futurestockbasedcompensationexpenseyearfive
|
2539 | USD |
CY2016Q1 | asmb |
Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
|
5430640 | USD |
CY2016Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
10130 | USD |
CY2016Q1 | asmb |
Operating Lease Expiration Month And Year
OperatingLeaseExpirationMonthAndYear
|
2016-08 | |
CY2016Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
5400000 | USD |
CY2016Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y10M24D | |
CY2015Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
64770366 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax
|
821585 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
63948781 | USD |